| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 0.43% | Morgan Stanley | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight |
| 07/24/2023 | 0.43% | Morgan Stanley | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight |
| 07/17/2023 | 0.43% | Morgan Stanley | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight |
| 06/26/2023 | 0.43% | Morgan Stanley | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight |
| 06/20/2023 | 0.43% | Morgan Stanley | → $42 | Reiterates | → Equal-Weight |
| 06/12/2023 | 0.43% | Morgan Stanley | → $42 | Reiterates | Equal-Weight → Equal-Weight |
| 05/31/2023 | 7.6% | JP Morgan | $52 → $45 | Maintains | Neutral |
| 05/09/2023 | 0.43% | Morgan Stanley | $44 → $42 | Maintains | Equal-Weight |
| 05/08/2023 | -1.96% | RBC Capital | $43 → $41 | Maintains | Sector Perform |
| 05/08/2023 | 64.99% | Raymond James | → $69 | Upgrades | Market Perform → Outperform |
| 02/27/2023 | 2.82% | RBC Capital | $53 → $43 | Maintains | Sector Perform |
| 02/27/2023 | 5.21% | Morgan Stanley | $57 → $44 | Maintains | Equal-Weight |
| 01/23/2023 | 12.86% | Jefferies | $49 → $47.2 | Upgrades | Underperform → Hold |
| 11/07/2022 | 26.73% | RBC Capital | $55 → $53 | Maintains | Sector Perform |
| 11/07/2022 | 36.3% | Morgan Stanley | $63 → $57 | Maintains | Equal-Weight |
| 11/07/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 10/13/2022 | 50.65% | Morgan Stanley | $61 → $63 | Maintains | Equal-Weight |
| 09/09/2022 | 45.86% | Morgan Stanley | $80 → $61 | Downgrades | Overweight → Equal-Weight |
| 08/15/2022 | 91.3% | Morgan Stanley | $79 → $80 | Maintains | Overweight |
| 08/08/2022 | 31.52% | RBC Capital | $62 → $55 | Maintains | Sector Perform |
| 07/15/2022 | 88.9% | Morgan Stanley | $80 → $79 | Maintains | Overweight |
| 05/09/2022 | 48.25% | RBC Capital | $60 → $62 | Maintains | Sector Perform |
| 02/28/2022 | 91.3% | Morgan Stanley | $77 → $80 | Maintains | Overweight |
| 01/27/2022 | — | Citigroup | Upgrades | Neutral → Buy | |
| 01/06/2022 | 84.12% | Morgan Stanley | $118 → $77 | Maintains | Overweight |
| 11/08/2021 | 55.43% | RBC Capital | $64 → $65 | Maintains | Sector Perform |
| 08/19/2021 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 08/09/2021 | 53.04% | RBC Capital | $87 → $64 | Maintains | Sector Perform |
| 05/10/2021 | 182.16% | Morgan Stanley | $117 → $118 | Maintains | Overweight |
| 04/14/2021 | — | Barclays | Upgrades | Equal-Weight → Overweight | |
| 03/11/2021 | 179.77% | Morgan Stanley | $129 → $117 | Maintains | Overweight |
| 02/22/2021 | 139.12% | Raymond James | → $100 | Upgrades | Market Perform → Outperform |
| 01/19/2021 | 208.46% | Morgan Stanley | $159 → $129 | Upgrades | Equal-Weight → Overweight |
| 11/19/2020 | 306.5% | Maxim Group | → $170 | Initiates Coverage On | → Buy |
| 10/21/2020 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
| 10/13/2020 | 280.2% | Morgan Stanley | $158 → $159 | Maintains | Equal-Weight |
| 08/25/2020 | — | Jefferies | Downgrades | Buy → Hold | |
| 08/24/2020 | 194.12% | HC Wainwright & Co. | $270 → $123 | Downgrades | Buy → Neutral |
| 08/21/2020 | 277.81% | Morgan Stanley | $221 → $158 | Maintains | Equal-Weight |
| 08/21/2020 | 220.42% | B of A Securities | $148 → $134 | Maintains | Underperform |
| 08/19/2020 | 220.42% | Cantor Fitzgerald | $192 → $134 | Maintains | Neutral |
| 08/10/2020 | 428.46% | Morgan Stanley | $224 → $221 | Maintains | Equal-Weight |
| 07/15/2020 | 435.63% | Morgan Stanley | $226 → $224 | Maintains | Equal-Weight |
| 07/10/2020 | 361.5% | Stifel | $298 → $193 | Downgrades | Buy → Hold |
| 05/21/2020 | 545.62% | HC Wainwright & Co. | $302 → $270 | Maintains | Buy |
| 04/15/2020 | 440.41% | Morgan Stanley | $220 → $226 | Maintains | Equal-Weight |
| 03/18/2020 | 275.42% | RBC Capital | $175 → $157 | Upgrades | Underperform → Sector Perform |
| 03/02/2020 | 378.24% | JP Morgan | $205 → $200 | Maintains | Neutral |
| 02/26/2020 | 593.45% | Nomura | $209 → $290 | Maintains | Buy |
| 02/26/2020 | 426.06% | Morgan Stanley | $215 → $220 | Maintains | Equal-Weight |
| 02/25/2020 | 359.11% | Cantor Fitzgerald | $187 → $192 | Downgrades | Overweight → Neutral |
| 02/24/2020 | 622.14% | HC Wainwright & Co. | $205 → $302 | Maintains | Buy |
| 02/24/2020 | 409.33% | B of A Securities | → $213 | Downgrades | Neutral → Underperform |
| 02/20/2020 | 318.46% | RBC Capital | → $175 | Downgrades | Sector Perform → Underperform |
| 01/06/2020 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 12/20/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 12/18/2019 | — | Citigroup | Downgrades | Buy → Neutral | |
| 12/17/2019 | 414.11% | Morgan Stanley | $193 → $215 | Downgrades | Overweight → Equal-Weight |
| 12/13/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 12/02/2019 | 375.85% | B of A Securities | → $199 | Initiates Coverage On | → Neutral |
| 11/15/2019 | 277.81% | RBC Capital | $152 → $158 | Maintains | Sector Perform |
| 10/29/2019 | 361.5% | Morgan Stanley | $200 → $193 | Maintains | Overweight |
| 09/10/2019 | 378.24% | Morgan Stanley | → $200 | Reinstates | → Overweight |
| 09/09/2019 | 378.24% | Morgan Stanley | → $200 | Reinstates | → Overweight |
| 07/31/2019 | — | UBS | Upgrades | Neutral → Buy | |
| 07/29/2019 | 399.76% | Nomura | $140 → $209 | Maintains | Buy |
| 07/29/2019 | — | Jefferies | Downgrades | Buy → Hold | |
| 07/15/2019 | 349.55% | Stifel | $121 → $188 | Maintains | Buy |
| 07/10/2019 | — | Credit Suisse | Assumes | → Outperform | |
| 04/29/2019 | 232.38% | Morgan Stanley | $138 → $139 | Maintains | Overweight |
| 03/29/2019 | 258.68% | HC Wainwright & Co. | $136 → $150 | Maintains | Buy |
| 03/28/2019 | 225.2% | HC Wainwright & Co. | → $136 | Initiates Coverage On | → Buy |
| 12/19/2018 | 210.86% | Cantor Fitzgerald | → $130 | Initiates Coverage On | → Overweight |
| 12/13/2018 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 11/15/2018 | 275.42% | Raymond James | → $157 | Initiates Coverage On | → Strong Buy |
| 11/05/2018 | 213.25% | Morgan Stanley | $127 → $131 | Maintains | Overweight |
| 10/30/2018 | 234.77% | Nomura | $124 → $140 | Maintains | Buy |
| 10/26/2018 | 115.21% | Credit Suisse | $92 → $90 | Maintains | Neutral |
| 09/12/2018 | 165.42% | Stifel | $109 → $111 | Maintains | Buy |
| 08/07/2018 | 119.99% | Credit Suisse | $85 → $92 | Maintains | Neutral |
| 08/06/2018 | 203.68% | Morgan Stanley | $126 → $127 | Maintains | Overweight |
What is the target price for Galapagos (GLPG)?
The latest price target for Galapagos (NASDAQ: GLPG) was reported by Morgan Stanley on July 31, 2023. The analyst firm set a price target for $42.00 expecting GLPG to rise to within 12 months (a possible 0.43% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Galapagos (GLPG)?
The latest analyst rating for Galapagos (NASDAQ: GLPG) was provided by Morgan Stanley, and Galapagos reiterated their equal-weight rating.
When is the next analyst rating going to be posted or updated for Galapagos (GLPG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Galapagos, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Galapagos was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
Is the Analyst Rating Galapagos (GLPG) correct?
While ratings are subjective and will change, the latest Galapagos (GLPG) rating was a reiterated with a price target of $42.00 to $42.00. The current price Galapagos (GLPG) is trading at is $41.82, which is out of the analyst's predicted range.